Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines.

52W Range

85thpctl

Volume

0.54×avg

Market Cap

8.64BUSD

P/E Ratio

-7.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Vaxcyte, Inc.

PCVXNASDAQ Global Select·USD·Closed

Vaxcyte, Inc.

PCVXNASDAQ·USD·Closed

$59.84

−2.16%

$59.84

−$1.32 (2.16%)

52W Range

85thpctl

Volume

0.54×avg

Mkt Cap

8.64BUSD

P/E

-7.8TTM

Div Yield

–ann

PCVX: Vaxcyte, Inc. Stock Analysis | finqOS